Thus it is established that imidazolyl-lactate is metabolized via histidine whereas imidazolylpropionate enters the histidine degradation pathway after conversion into urocanate.
1. Imidazol-5-ylpropionate and imidazol-5-yl-lactate are degraded by Pseudomonas testosteroni via inducible pathways. 2. Growth on either compound as the sole source of carbon results in the induction of the enzymes for histidine catabolism. 3. The pathway of histidine degradation in this organism, a non-fluorescent Pseudomonad, is shown to be the same as that operating in Pseudomonasfluorescens and Pseudomonasputida. It consists of the successive formation of urocanate, imidazol-4-on-5-ylpropionate, N-formimino-Lglutamate, N-formyl-L-glutamate and glutamate. 4. Whole cells ofP. testosteroni accumulate urocanate in the reaction mixture when incubated with imidazolylpropionate, but only after an adaptive lag period which is removed by previous growth on imidazolylpropionate as the source ofcarbon. 5. Imidazolyl-lactate is oxidized to imidazolylpyruvate, which then gives rise to histidine by specific transamination with L-glutamate. 6 . Cells grown on histidine, urocanate or imidazolylpropionate are also able to degrade imidazolyllactate. 7. Mutants lacking urocanase are unable to grow on imidazolylpropionate, imidazolyl-lactate, histidine or urocanate. One with impaired histidase activity cannot utilize histidine or imidazolyl-lactate, but grows normally on imidazolylpropionate or urocanate. A mutant unable to grow on imidazolylpropionate is indistinguishable from the wild-type with respect to growth on histidine, imidazolyl-lactate or urocanate. 8. Thus it is established that imidazolyl-lactate is metabolized via histidine whereas imidazolylpropionate enters the histidine degradation pathway after conversion into urocanate.
Imidazol-5-ylpropionate and imidazol-5-yl-lactate are normally occurring metabolites of histidine that are excreted in the urine of a number of mammals (Baldridge & Tourtellotte, 1958) . Imidazolylpropionate is formed by the reduction of urocanate (Sen et al., 1962) predominantly, if not exclusively, by gut bacteria (A. V. Emes & H. Hassall, unpublished work) , and imidazolyl-lactate arises from the reduction of imidazolylpyruvate, which is formed from histidine by transamination (Spolter & Baldridge, 1963) . These metabolites are therefore not intermediates of the main pathway of histidine catabolism and they do not appear to be degraded further by mammalian systems.
In bacteria, Westley & Ceithaml (1956) found that imidazolyl-lactate and imidazolylpyruvate would satisfy the growth requirements of a large number of histidine auxotrophs of Escherichia coli W, and concluded that endogenously supplied imidazolyl-lactate was converted via imidazolylpyruvate into histidine. The reverse of this reaction sequence was shown to be responsible for the formation of imidazolyl-lactate by E. coli B grown under conditions of nitrogen limitation in a medium containing histidine (Hedegaard et al., 1966) . Since the imidazolyl-lactate that accumulated in the medium was subsequently used by the organism, these authors suggested that it was possibly metabolized via a pathway involving ringopening and the formation of one or several acyclic compounds.
In studies with other bacteria, imidazolylpropionate has been of interest because of its ability to function as a gratuitous inducer for the enzymes of the histidine degradative pathway in Klebsiella aerogenes, Salmonella typhimurium and Pseudomonas aeruginosa (Magasanik, 1963; Schlesinger & Magasanik, 1965; Lessie & Neidhardt, 1967) .
The pathway ofhistidine degradation in fluorescent species ofPseudomonas (Pseudomonasfluorescens and P. aeruginosa) has been shown to proceed via urocanate, 3-(imidazol-4-on-5-yl)propionate, N-formimino-L-glutamate and N-formyl-L-glutamate to L-glutamate (Tabor & Mehler, 1954; Lessie & Neidhardt, 1967) . A similar pathway operates in K. aerogenes and S. typhimurium, but in these organisms formiminoglutamate is hydrolysed directly to glutamate without the intermediate formation of formylglutamate (Scheme 1).
By using enrichment culture techniques, we have been able to isolate a number of organisms that are able to use either imidazolylpropionate (Hassall & Rabie, 1966) or imidazolyl-lactate (Hassall, 1966) as the sole source of carbon and energy for growth; all of these organisms are non-fluorescent species of Pseudomonas. The present paper describes the degradation of imidazolylpropionate and imidazolyllactate by one of these organisms, Pseudomonas testosteroni. Our results show that both compounds are adaptively metabolized and that, apart from the initial steps, their degradation is brought about by the enzymes normally concerned with the catabolism of histidine.
Histidine degradation in this organism follows the pathway used by the fluorescent species of Pseudomonas. A preliminary account of some of these findings has been published (Coote & Hassall, 1969) .
Materials and Methods

Characteristics of the organism
The organism used was isolated from soil by enrichment culture in a medium containing imidazolylpropionate as the sole source of carbon. It was originally identified as Pseudomonas acidovorans (Hassall, 1966) , but a more detailed investigation, by using the criteria of Stanier et al. (1966) (Hughes, 1951) . Occasionally, as indicated in the text, they were disintegrated by exposure of 3 ml of suspension for 1.5 min to the output of a Dawe Soniprobe type 1130A ultrasonic disintegrator used at a setting of I A, by grinding with an equal weight of alumina, or by passage through a French pressure cell (Milner et al., 1950) (Hassall & Greenberg, 1963) . Other solvents used for the further characterization of intermediates were: B, butan-1 -ol-pyridine-water (1:1:1, by vol.) and C, butan-1-ol-acetic acidwater (4:1:1, by vol.) (Sen et al., 1962 (Hall, 1952) . Urocanate was also detected as a dark-purple spot when papers were viewed in u.v. light. Other compounds were detected as described previously (Hassall, 1971) .
Identification of 14C-labelled products. Small amounts of 14C-labelled products were identified (after elution from unsprayed chromatograms) by co-chromatography and co-electrophoresis. The radioactive material was mixed with authentic sample and the mixture chromatographed in two-dimensions on paper or subjected to paper electrophoresis. The radioactive areas were located by radioautography on Kodirex (Kodak Ltd., London W.C.2, U.K.) X-ray film and the papers subsequently treated with the appropriate reagent for the detection of the unlabelled carrier compound. When the radioautogram and paper were superimposed, the coincidence ofradioactive area and chemically detected spot was obtained in all systems.
Identification ofurocanate as aproduct ofimidazolylpropionate metabolism. A reaction mixture (200ml) containing 0.8 g of imidazolylpropionate, 6mmol of KH2PO4 and 300mg dry wt. of cells previously grown with imidazolylpropionate as the carbon source was incubated at 30°C for 6h. The cells were removed by filtering the suspension through an Oxoid cellulose acetate filter and the filtrate, with E277 26.7, was evaporated to dryness on a rotary evaporator. The dried material was dissolved in 10ml of hot water and the pH adjusted to approx. pH4.5 with acetic acid. The crystals, which appeared as the solution cooled, were collected by filtration and recrystallized from 5ml of hot water. The final product consisted of 40mg of fine white needles which melted at 2230C (uncorr.) (urocanic acid dihydrate; m.p. 225°C; Mehler & Tabor, 1953) . The u.v.-absorption spectra in acidic, neutral and alkaline solutions and the i.r. spectrum were identical with those obtained for authentic urocanic acid dihydrate (Found: C, 41.6; H, 5.7; N, 16.0. Calc. for C6H6N202,2H20: C, 41.5; H, 5.7; N, 16.1 %).
Measurement ofradioactivity. Material was assayed on aluminium planchets in a Nuclear-Chicago gasflow counter. The radioactivity of compounds on unsprayed chromatograms was determined by cutting out the appropriate area of paper and placing it directly on to a lightly gummed planchet. The radioactivity of whole cells collected by filtration on Oxoid discs was determined in the same way.
Spectrophotometry. Continuous changes in extinction were monitored automatically in a Gilford 2000 multiple-sample absorbance indicator fitted with a Unicam SP. 500 monochromator. U.v. and i.r. spectra were determined with Unicam SP. 800 and Unicam SP. 200 spectrophotometers respectively.
Assay of histidine aminotransferase activity. The assay used was based on the method described by Spolter & Baldridge (1963) for the assay of histidinepyruvate aminotransferase. The formation of the enol-borate complex of imidazolylpyruvate was followed spectrophotometrically at 293 nm (E 12000) in borate-arsenate buffer. The complete system (3.5ml) consisted of 2mmol of sodium borate (pH8.0), 20,umol of sodium arsenate, 80,umol of EDTA, 100,mol of L-histidine, 100,umol of oxo acid and 0.1 ml of enzyme preincubated for IOmin with 75,ug of pyridoxal 5'-phosphate/ml. Oxo acid was omitted from the control reaction mixture. One unit of enzyme activity was defined as the formation of 1,umol of product/min at 30°C. When activity towards phenylalanine and tyrosine was assayed, extinction changes were followed at the appropriate wavelength for the enol-borate complex formed (phenylpyruvate, 6310 12400; p-hydroxyphenylpyruvate, e300 9150).
Assay of imidazolyl-lactate oxidase activity. The ability of preparations to form imidazolylpyruvate from imidazolyl-L-lactate was measured spectrophotometrically by following the formation of the enol-borate complex of imidazolylpyruvate at 293rnm. The reaction mixture contained 10,umol of imidazolyl-L-lactate, 2mmol of sodium borate, 20,umol of sodium arsenate (pH 8.0) and sample to a total volume of 3.5ml. A control reaction mixture from which imidazolyl-lactate was omitted showed no change in E293.
Removal of cells from samples of suspension. For two types of experiment it was necessary to remove cells quantitatively from samples of suspension: first, to determine the extracellular accumulation of urocanate by measurement of the E277 of the filtrate, and secondly, to measure the uptake of 14C-labelled substrates by whole cells. In each case, the cells were removed by filtering the suspension, with suction, through 2.4cm diam. Oxoid filters held in a stainlesssteel filter-tower assembly. When the cells were needed for the measurement of radioactivity, the filter was washed twice with 3 ml of water and allowed to dry at 35°C.
Chemicals
Urocanic acid was synthesized enzymically by the method of Mehler et al. (1955) . [2-14C]Urocanic acid was prepared from [ring-2-14C]histidine by a similar procedure except that the product was isolated by elution from Amberlite IRC-50 (Na+ form) with a gradient of 0-0.1 M-acetic acid (Rao & Greenberg, 1960 Imidazolyl-L-lactic acid was prepared by incubating 0.2ml of 0.5mM-[ring-2-14C]histidine (5,Ci) with 0.1ml of 50%-saturated aq. NaNO2 at 30°C for 30min. The product was purified by paper chromatography in solvent C and high-voltage paper electrophoresis at pH3.6. Imidazolylpropionic acid was prepared by the catalytic hydrogenation of urocanic acid (Mehler & Tabor, 1953; Kraml & Bouthillier, 1955 (Coote & Hassall, 1973 (Hassall & Greehberg, 1963 degradation products of the substrate could be detected. Also, the preparation of cell extracts by a variety of means, including treatment with lysozyme and EDTA, followed by osmotic shock (Flessel et al., 1967) gave no improvement in the recovery ofactivity. There are, however, two major difficulties with this type of experiment. First, if the initial step in the metabolism of the substrate is very slow compared with the following steps, then no intermediates will accumulate. Secondly, where a slow disappearance of the substrate is observed there is always the possibility that this might be brought about by residual whole cells.
Extracellular accumulation ofurocanate by whole cells incubated with imidazolyipropionate
When washed cells, grown with imidazolylpropionate as the source of carbon, were resuspended in ftesh medium containing imidazolylpropionate there was an immediate extracellular accumulation of urocanate (Hassall & Rabie, 1966) ; this accumulation was not affected by the presence ofchloramphenicol in the resuspension medium (Fig. 2) . Cells grown previously on urocanate, when incubated with imidazolylpropionate, only accumulated urocanate after a lag period of some 2-2jh. Further, the accumulation was prevented by chloramphenicol in the reaction mixture. These results indicate that cells grown on urocanate require the induction of a permease or an enzyme system (or both) before they can metabolize imidazolylpropionate. This is in complete agreement with the manometric results shown in Table 1 .
Uptake of [14C]imidazolylpropionate by whole cells
To determine whether the non-metabolism of imidazolyipropionate by cells grown on urocanate was due to non-permeability of the cells to the substrate or to the lack ofan enzyme system, the ability of cells to accumulate ["4C]imidazolylpropionate was investigated.
Cells grown respectively on urocanate, imidazolylpropionate and L-glutamate were harvested, washed and resuspended in media containing [2-'4C]imidazolylpropionate. The radioactivity of the cells in each suspension was determined at specific timeVol. 132 intervals (Fig. 3 ). There was a rapid uptake of radioactivity by cells that had been grown on urocanate or imidazolylpropionate but not by those grown on glutamate. The radioactivity of the cells grown on imidazolylpropionate decreased marktedly after the initial rise. This was assumed to be due to the metabolism of imidazolylpropionate, rather than to its telease into the suspension medium. The assumption would appear to be valid, since the total radioactivity of a dried sample of this reaction mixture decreased to some 10% ofthe initial value overa 15 mi reaction period. The total radioactivity in each of the other two reaction mixtures remained constant. Exponentially growing cells were harvested from media containing either imidazolylpropionate or urocanate as the carbon source. They were washed and resuspended to 1.2mg dry wt./ml in 10ml of reaction mixture, which contained 150bmol of imidazolylpropionate and 200,umol of KH2PO4 buffer adjusted to pH 7.0 with 5M-NaOH. Chloramphenicol, where present, was added at 100 jtg/ml. Samples (1 ml) were taken at the times indicated and filtered through Oxoid discs. Urocanate was estimated spectrophotometrically at 277nm (E 18 800) after tenfold dilution of samples of filtrate with water. Urocanate-grown cells, with (-) and without (o) chloramphenicol. Imidazolylpropionate-grown cells, with (e) and without (o) chloramphenicol. J. 0. COOTE AND H. 14ASSALL L-Histidine-2-oxoglutarate aminotransferase: the formation ofhistidine from imidazolylpyruvate Cell extracts were examined for their ability to catalyse the transamination of imidazolylpyruvate and L-histidine. Aminotransferase activity was first assayed in extracts of cells grown on imidazolyllactate with imidazolylpyruvate as the substrate. The change in E282 was followed when various amino acids were added to the reaction mixture. In the absence of L-glutamate no decrease in extinction occurred, and no activity was observed if L-alanine or L-aspartate replaced L-glutamate.
An assay system some five times more sensitive was obtained by following the reaction in the reverse direction, borate being used to complex the imidazolylpyruvate formed and the increase in E293 due to this complex being measured. Table 2 shows the specificity of histidine aminotransferase activity towards a number of oxo acids. Of the oxo acids used 2-oxoglutarate gave the highest activity.
The specificity of the enzyme with respect to the amino acid could only be tested within the limits of the spectrophotometric assay procedure, which is dependent on the formation of an enol-borate complex of the oxo acid produced. The assay is suitable for monitoring transamination of phenylalanine or tyrosine, since they give rise to oxo acids, phenylpyruvate and p-hydroxyphenylpyruvate, which form enol-borate complexes with characteristic absorption spectra (E310 12400 and E300 9150 respectively).
However, a lower concentration of substrate is necessary when tyrosine is used, because of its poor solubility. reaction was started by the addition of 5ml of the appropriate cell suspension (lmg dry wt./ml) and 1 ml samples were withdrawn at the times shown for the determination of radioactivity in the cells. Table 2 . Specificity of L-histidine-2-oxoglutarate aminotransferase activity in crude cell-free extracts of P. testosteroni Extracts were prepared from cells grown in media containing either imidazolyl-L-lactate or succinate as the sole source ofcarbon. Aminotransferase activity towards aromatic amino acids was measured spectrophotometrically by following the rate of appearance of the enol-borate complex of the oxo acid formed. For the determination of rates with different oxo acids 100,umol of L-histidine and 100,umol of oxo acid were present. Other reaction mixtures contained 100,umol of 2-oxoglutarate and 20p,mol of amino acid. Table 2 also shows that an extract prepared from cells grown on imidazolyl-lactate had a general aminotransferase activity towards the aromatic amino acids. The activity towards phenylalanine and tyrosine was again specific for 2-oxoglutarate as the oxo acid, since only minimal activity was obtained with glyoxylate, pyruvate, 2-oxobutyrate or 4-methyl-2-oxo-pentanoate. A low, but distinct, basal activity of the enzyme towards L-histidine was detected in an extract of cells grown on succinate as the carbon source. Surprisingly, the activity of this extract towards phenylalanine was comparable with that of the extract of cells grown on imidazolyl-lactate. This activity towards phenylalanine in uninduced cells strongly suggests that the enzyme catalysing the transamination of histidine is not responsible for all the activity towards phenylalanine and that this, in part, could be due to an aminotransferase normally concerned with the biosynthesis of phenylalanine.
Formation of imidazolylpyruvate from imidazolyllactate
Three distinct enzyme systems were recognized that could catalyse the formation of imidazolylpyruvate from imidazolyl-lactate. These were imidazolyllactate-NADP+ oxidoreductase, and particulate and non-particulate imidazolyl-lactate oxidases.
The equilibrium position of the reaction catalysed by imidazolyl-lactate-NADP+ oxidoreductase is strongly in favour of imidazolyl-lactate formation, since the reaction could only be demonstrated in this direction. The relative rates of oxidation of NADH and NADPH were determined with imidazolylpyruvate, phenylpyruvate and p-hydroxyphenylpyruvate as substrates by using an extract of cells grown on imidazolyl-lactate (Table 3 ).
The formation of imidazolylpyruvate from imidazolyl-lactate, in the absence of added cofactors, was followed in borate buffer by measuring the increase in E293 caused by the formation of the enol-borate complex of the oxo acid. Table 4 . Intracellular distribution of imidazolyl-lactate oxidase activity in P. testosteroni Cells were grown with either imidazolyl-L-lactate or L-glutamate as the carbon source and were collected by centrifugation and resuspended to a density of 5mg dry wt./ml. Samples of suspension (5ml) were subjected to sonic treatment and centrifuged at lOOOOg for 15min. The supernatant solutions were re-centrifuged at 45000g for 60min. The pellets from the final centrifugation were suspended in 0.1 M-KH2PO4 buffer (pH7.0) to the original volume allowing for the removal of a sample for assay at each stage. Each fraction was assayed for its ability to form imidazolylpyruvate from imidazolyl-L-lactate by using the enol-borate system as described in the Materials When soluble extracts of cells able to oxidize imidazolyl-lactate were subjected to polyacrylamidegel electrophoresis and the resulting gels incubated in a reaction mixture consisting of imidazolyl-lactate, phenazine methosulphate and Nitro Blue Tetrazolium, an intense, purple band was obtained (Plate 1). Phenyl-lactate or p-hydroxyphenyl-lactate would also act as substrates for this reaction, indicating a certain degree of non-specificity of action. However, no activity was detected in extracts ofcells grown with either succinate or glutamate as the carbon source. The possibility of there being a similar oxidase concerned with the metabolism of imidazolylpropionate was investigated by using the same phenazine methosulphate-Nitro Blue Tetrazolium assay system but with imidazolylpropionate as substrate. The results were negative in that no band of activity was observed, even when extracts were prepared from cells previously grown with imidazolylpropionate as the carbon source.
Studies with mutants ofP. testosteroni It was found during the screening of potential mutants that those clones showing weak growth on L-histidine plates also showed weak growth on imidazolyl-lactate plates. Similarly, mutants selected because of an inability to grow on imidazolyl-lactate were frequently found to grow poorly on L-histidine. Thus mutant 11/13, a 'leaky' histidase-mutant, grew readily on urocanate or imidazolylpropionate but showed only poor growth on histidine or imidazolyl-lactate plates even after 4 or 5 days. Revertants of this mutant, selected after heavy seeding of either histidine or imidazolyl-lactate plates, grew readily on both histidine and imidazolyl-lactate. Mutant A26, a urocanase-mutant, showed no growth on histidine, Table 5 . Stoicheiometry of02 consumption during theformation ofimidazolylpyruvatefrom imidazolyl-L-lactate by a particulate preparation ofP. testosteroni The reaction vessel of the 02 electrode contained 1.6ml of borate-arsenate buffer (pH8.0) and 1 ml of particulate preparation from cells grown with imidazolyl-L-lactate as the carbon source; 0.2ml (20tmol) of imidazolyl-Llactate was added to start the reaction. 02 consumption was recorded and separate reactions were stopped by the addition of 0.2ml of 35 % (w/v) HCl04. The mixtures were centrifuged and 2ml of each supernatant solution was adjusted to pH 8.0 by the addition of 0.75 M-NaOH in borate buffer. Imidazolylpyruvate was estimated spectrophotometrically at 293 nm. A control reaction was used to correct for endogenous 02 consumption and as a blank for the determination of imidazolylpyruvate.
Reaction Cells were grown in the presence ofimidazolyl-L-lactate with succinate as the carbon source and (NH4)2SO4 as the nitrogen source. They were harvested, washed and resuspended to approx. 7mg dry wt./ml. Samples were disrupted by ultrasonic treatment. Whole cells and disintegrated preparations were assayed in 3 ml of reaction mixture containing 1 ,umol of substrate, 100,umol of Tris buffer (pH 8.0) and 0.1 ml of preparation at 30°C. The amount of urocanate formed was calculated from the change in E277. The decrease in extinction caused by the metabolism of imidazolylpyruvate was allowed for in the appropriate calculations.
Rate of urocanate formation (nmol/min per mg dry wt.) o k S e l V -¢ 3 S t ; ; * : Overnight growth of mutant A26 (urocanase-) in liquid culture in L-histidine-succinate medium or in succinate-NH4+ medium in the presence of imidazolyl-lactate or imidazolylpropionate gave an accumulation of urocanate in the growth medium.
The activity of various cell preparations of mutant A26, with respect to their ability to form urocanate from a precursor, was assayed spectrophotometrically by following the increase in E277 of reaction mixtures.
Provided that the cell density was not too high, this activity could be assayed by using whole cells or sonicated preparations. after previous growth in succinate-NH4+ medium containing L-imidazolyl-lactate, accumulated urocanate from imidazolyl-lactate, imidazoly}pyruvate and histidine, with the accumulation from histidine being the slowest (Table 6 ). Sonic disruption of the cell suspension caused a significant decrease in the rate of urocanate accumulation from imidazolyllactate and imidazolylpyruvate but greatly stimulated that from histidine, indicating that there is restricted entry of histidine into whole cells. incubation with imidazolylpyruvate unless L-glutamate was added to the reaction mixture (Fig. 4) . A steady increase in extinction was then observed, and concomitant with this there was a change in Ainax. from 282nm to 277 nm, corresponding to the conversion of imidazolylpyruvate into urocanate. Soluble, cell-free extracts ofmutant A26 did not accumulate urocanate from imidazolyl-lactate although, as shown in Table 6 , sonicated preparations of broken cells would do so. This conversion was examined quantitatively by using [2-14C]imidazolyl-lactate in a reaction mixture containing sonically disrupted cells previously grown in the presence of imidazolyl-lactate. The results (Fig. 5) show that at any particular time during the reaction, all the radioactivity lost from imidazolyl-lactate was accounted for as urocanate.
Discussion
The pathways of degradation of imidazolylpropionate and imidazolyl-lactate, and their relationship to the pathway for histidine degradation, are shown in Scheme 2. That the degradation of histidine proceeds via formylglutamate, as in P. fluorescens, Pseudomonasputida and P. aeruginosa, is worthy ofemphasis since in many respects the Pseudomonads of the fluorescent group differ substantially from those of the acidovorans group, of which P. testosteroni is a member. Good examples of these differences are found in the pathways by which representatives of the two groups of organism degrade tryptophan and in the way in which they accomplish the cleavage of the aromatic ring when oxidizing compounds such as protocatechuate (Stanier et al., 1966) .
Although our initial experiments showed that extracts of cells grown on imidazolylpropionate were able to degrade urocanate, this alone was not sufficient to establish that urocanate was an intermediate ofimidazolylpropionatecatabolism. Since imidazolylpropionate has been shown to be a gratuitous inducer for the enzymes of the histidine pathway in a number of organisms (Magasanik, 1963; Schlesinger & Magasanik, 1965; Lessie & Neidhardt, 1967) it was possible that it behaved similarly in P. testosteroni without actually being degraded via urocanate. Even with the assumption that some enzymes of the histidine pathway were utilized for the degradation of imidazolylpropionate it was still uncertain which was the point of entry into this pathway. If imidazolylpropionate were first metabolized to urocanate then the co-ordinate induction of histidase and urocanase in this organism would explain the presence of histidase. But similarly, if, as is possible, imidazolonylpropionate hydrolase (EC 3.5.2.7) were co-ordinately induced with histidase and urocanase, then imidazolylpropionate might be hydroxylated to imidazolonyl- The hydroxylation of imidazolylpropionate to imidazolonylpropionate was at first considered to be the most-probable initial step, particularly since an analogous reaction has been shown to occur for the degradation of imidazolylacetate in P. fluorescens (Hayaishi et al., 1957) . This hydroxylation is catalysed by a mixed-function oxygenase (EC 1.14.1.5) that utilizes NADH as the reductant. However, no imidazolylpropionate hydroxylase activity could be detected in extracts of P. testosteroni grown on imidazolylpropionate. It is perhaps also ofsignificance that P. testosteroni cannot utilize imidazolylacetate as the sole source of carbon for growth.
The accumulation of urocanate from imidazolylpropionate by cells grown with imidazolylpropionate as the carbon source indicates clearly that urocanate is a degradation product. The extent of this accumulation, caused by the inhibition of urocanase (Hassall & Rabie, 1966) , and the fact that the equilibrium position of the urocanase reaction is greatly in favour of imidazolonylpropionate formation, does not allow the accumulation of urocanate to be explained in terms of the initial conversion of imidazolylpropionate into imidazolonylpropionate followed by a reversal of the urocanase reaction.
The independent nature of the system catalysing the formation of urocanate from imidazolylpropionate is shown by a number of experiments. First, there is some evidence from the fact that cells grown on histidine, urocanate or imidazolyl-lactate cannot oxidize imidazolylpropionate as determined manometrically. Secondly, cells grown on urocanate are unable to accumulate urocanate from imidazolylpropionate. Both these findings contrast with the observation of Hug et al. (1966) that cells of P. fluorescens were able to oxidize imidazolylpropionate without a lag period after preincubation with urocanate. The results of the experiments following the uptake of [14C]imidazolylpropionate show that although there is an inducible system for the transport of imidazolylpropionate into the cell, this system is present after growth of the organism on urocanate. Thus non-metabolism of imidazolylpropionate under these conditions is due to the non-induction of the enzyme system necessary for its conversion into urocanate rather than to the non-entry ofthe substrate into the cell. Results presented in the following paper (Coote & Hassall, 1973) show that, as in K. aerogenes (Schlesinger & Magasanik, 1965) L-Histidine L-Glutamate -Formyl-L-glutamate -Formimino-L-glutamate -Imidazolonylpropionate Scheme 2. Degradation pathways of imidazolyl-L-lactate, imidazolylpropionate and L-histidine in Pseudomonas testosteroni oxidize imidazolylpropionate. The enzyme system responsible for the initial transformation of this compound could be membrane-bound, since it appears to be readily inactivated once the structural integrity of the cell is destroyed. Alternatively, it is possible that we have not succeeded in obtaining the necessary reaction conditions when using preparations from disrupted cells.
The pathway of imidazolyl-lactate degradation proceeds via imidazolylpyruvate and histidine to urocanate. However, the enzymology of the first step, the formation of imidazolylpyruvate from imidazolyl-lactate, is somewhat obscure and, as in imidazolylpropionate metabolism, there may be considerable loss of enzymic activity on disruption of the cells. It is probable that the imidazolyl-lactate-NADP oxidoreductase has insufficient activity in the direction of imidazolylpyruvate formation for it to be of significance in the oxidation of imidazolyllactate as originally suggested (Coote & Hassall, 1969) . The particulate imidazolyl-lactate oxidase, although apparently constitutive and of low specificity, seems likely to be the enzyme catalysing the Vol. 132 formation of imidazolylpyruvate, since it has higher measurable activity than the oxidoreductase. The role of the enzyme detected on polyacrylamide gels by coupling the oxidation of imidazolyl-lactate to the reduction ofNitro Blue Tetrazolium is not clear, since its activity has not been shown by any other method. This could simply reflect the low activity of this enzyme, since the gel assay procedure is a very sensitive one. The enzyme remains of interest, and possibly of relevance to the degradation of imidazolyl-lactate, because, unlike the particulate oxidase, it is only present in extracts prepared from cells that are able to oxidize imidazolyl-lactate.
The second reaction in the pathway of imidazolyllactate metabolism, that catalysed by the aminotransferase, is freely reversible. The enzyme is specific for L-glutamate and has a high activity in cells that are induced with respect to imidazolyl-lactate degradation. Similar transamination reactions have been reported by other workers. Feldman & Gunsalus (1950) detected the formationofL-glutamate from L-histidine and 2-oxoglutarate by using a strain ofP. fluorescens unadapted to L-histidine. In addition, an enzyme for 421 422 J. G. COOTE AND H. HASSALL the reversible transamination of L-histidine, found in E. coli B (Feldman & Gunsalus, 1950; Wickramasinghe etal., 1967 ) and E. coli W (Westley & Ceithaml, 1956 ) has also been shown to occur in other organisms, including K. aerogenes and Proteus vulgaris (Brevet et al., 1968) . There is no evidence, however, that this is an inducible enzyme or that it plays a major role in any catabolic pathway.
Further support is given to the validity of the pathways shown in Scheme 2 by the results of the experiments with the various mutant strains ofthe organism. The urocanase-mutant is unable to grow on histidine, imidazolylpropionate or imidazolyl-lactate and accumulates urocanate in the medium when presented with these compounds. A mutant lacking histidase cannot grow on histidine or on imidazolyl-lactate but it is still able to grow on either imidazolylpropionate or urocanate. A third mutant, unable to grow on imidazolylpropionate, behaves normally with respect to growth on urocanate, histidine or imidazolyl-lactate.
